Pharmacists’ Role in Reducing Problematic Opioid Use
A special issue of Pharmacy (ISSN 2226-4787). This special issue belongs to the section "Pharmacy Practice and Practice-Based Research".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 7825
Special Issue Editor
Special Issue Information
Dear Colleagues,
Pharmacy and pharmacists have always had a role in reducing the misuse of opioids. In the past, this was more of a policing capacity in which pharmacists focused on preventing the misuse of opioids. However, this has changed as we have adopted a more caring approach from an understanding that opioid use can be problematic for individuals, by causing them harm, increasing the risk of overdose, and all the problems that can go along with drug dependence. Pharmacists’ role has developed into both a public health and clinical response to the considerable challenges faced by people struggling with pain management and or drug dependence. Pharmacists provide a range of services, care, and support that we want to highlight in this special issue of Pharmacy. From supporting people on opiate replacement treatment for drug dependence, identifying and providing harm reduction services to people using illicit/street drugs, providing specialist clinical support in drug treatment services, to providing new models of care and care pathways for those dependent to over the counter opioids or prescription opioids for pain. The aim of this special issue is to provide a platform to showcase novel and innovative practice and models of care. We welcome a full range of research and evaluation methodologies.
Prof. Dr. Catriona Matheson
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- harm reduction
- community pharmacy
- opioid misuse
- public health
- opioids
- addiction
- medication safety
- medication-assisted treatment
- harm minimization
